Objective
Adaptive immune responses are initiated in large and highly organized clusters of lymphocytes and antigen presenting cells, the secondary and tertiary lymphoid tissues (LTs). The development of secondary LTs, i.e. lymph nodes and Peyer's patches, is programmed and initiated in the sterile environment of the fetus. A cascade of events is triggered by lymphoid tissue inducer (LTi) cells, which recapitulates the inflammatory reaction and culminates in the formation of complex structures carrying specialized he matopoietic and stromal cells. The formation of tertiary LTs follows a similar pathway, but is induced after birth by commensal microbes, infection or injury. Chronic inflammation also leads to the spatial organization of the lesion and to tertiary LT formation, which may establish a positive feedback loop of lymphocyte activation.
The aim of our laboratory is to understand the mechanisms that lead to the formation of LTs during fetal life, in response to commensals, during infection and injury, and during the inflammatory reaction. The long-term goal is to develop new and specific tools for the modulation of pathologic inflammatory diseases, such as inflammatory bowel disease (IBD) and rheumatoid arthritis, or conversely, to induce the formation of LTs to enhance local immunity against infection or cancer.
The specific aims of this project are:
1. Understanding the fetal development of secondary LTs.
2. Understanding the post-natal formation and function of tertiary LTs.
3. Identifying lymphoid stromal cells initiating and supporting LT development.
4. Modulating pathologic inflammation through the control of LTs.
5. Inducing therapeutic LTs.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences inflammatory diseases
- medical and health sciences clinical medicine gastroenterology inflammatory bowel disease
- medical and health sciences basic medicine immunology
- medical and health sciences clinical medicine obstetrics fetal medicine
- medical and health sciences clinical medicine embryology
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2005-MOBILITY-8
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
PARIS
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.